CARDENE I.V. labels and packaging

Nicardipine
CARDENE I.V.® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packaging
CARDENE SR ® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packaging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Abdurahman Khalil, M.D. [2]

For patient information about Nicardipine, click here. Revised September 2010

CAR10-249

07-19-65-231

Package Label - Principal Display Panel - 0.2 mg (Dextrose diluent) Bag

Package Label - Principal Display Panel - 0.2 mg (Dextrose diluent) Carton

Package Label - Principal Display Panel - 0.2 mg (Sodium Chloride diluent) Bag

Package Label - Principal Display Panel - 0.2 mg (Sodium Chloride diluent) Carton

References

Adapted from the FDA Package Insert.